Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Codexis, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CDXS
Nasdaq
2830
www.codexis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Codexis, Inc.
Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board
- Feb 6th, 2025 9:05 pm
Codexis (NASDAQ:CDXS) investors are sitting on a loss of 79% if they invested three years ago
- Feb 6th, 2025 12:52 pm
Codexis Appoints Christos Richards to Board of Directors
- Jan 16th, 2025 9:05 pm
Codexis Announces New Employment Inducement Grants
- Jan 10th, 2025 9:05 pm
Is There An Opportunity With Codexis, Inc.'s (NASDAQ:CDXS) 22% Undervaluation?
- Jan 10th, 2025 12:31 pm
Codexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week
- Dec 14th, 2024 12:14 pm
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
- Nov 19th, 2024 9:05 pm
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
- Nov 14th, 2024 9:05 pm
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
- Nov 12th, 2024 9:05 pm
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
- Nov 11th, 2024 9:05 pm
Codexis to Participate in Upcoming Healthcare Conferences
- Nov 4th, 2024 9:05 pm
Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17
- Nov 3rd, 2024 1:18 pm
Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
- Nov 2nd, 2024 1:16 pm
Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ...
- Nov 1st, 2024 1:01 pm
Promising Penny Stocks On US Exchanges In November 2024
- Nov 1st, 2024 12:04 am
Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates
- Oct 31st, 2024 9:30 pm
Codexis: Q3 Earnings Snapshot
- Oct 31st, 2024 8:23 pm
Codexis Reports Third Quarter 2024 Financial Results
- Oct 31st, 2024 8:05 pm
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
- Oct 24th, 2024 8:05 pm
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
- Oct 22nd, 2024 8:05 pm
Scroll